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ABSTRACT
There is a rising incidence of several sexually
transmitted infections (STIs), many of which can
present with proctitis. Causative organisms
include Neisseria gonorrhoeae, Chlamydia
trachomatis, herpes simplex virus, Treponema
pallidum (syphilis), Giardia lamblia (giardiasis)
and Entamoeba histolytica (amoebiasis). This
paper outlines important clinical discriminators
and key investigations to distinguish these
organisms from non-infective pathology that
include inflammatory bowel disease, solitary
rectal ulcer syndrome and Behçet’s syndrome.
Management of these infections is described
and suggestions are made for successful
gastroenterology clinical consultation when an
STI is suspected.
INTRODUCTION
Patients presenting to secondary care
with symptoms of diarrhoea and rectal
bleeding may be found to have features
consistent with inflammatory bowel
disease (IBD) on endoscopic or radio-
logical investigation. The main differen-
tial diagnoses of infectious colitis,
ischaemic colitis and non-steroidal anti-
inflammatory drug enteropathy are well
understood and widely covered in the lit-
erature. However, there are several less
commonly encountered causes of intes-
tinal inflammation that may not respond
to, or be made worse by, immunosup-
pressant therapy intended for Crohn’s
disease or ulcerative colitis. Competency
2.c. of the 2010 Gastroenterology cur-
riculum (box 1) stipulates that UK trai-
nees must have an appreciation of the
range of potential aetiologies and the
investigative process of differential causes
of intestinal inflammation, in order to
guide appropriate and successful thera-
peutic intervention. In the UK and many
other western countries there has been a
sustained annual increase in the incidence
of sexually transmitted infections (STIs)
over the past decade.1 Several STIs
including gonorrhoea, chlamydia, syphilis
and herpes virus can manifest with symp-
toms and endoscopic features of proctitis.
This article outlines these diagnoses and
suggests key clinical features or important
diagnostic tests that may aid earlier diag-
nosis and appropriate treatment.
GONORRHOEA
Caused by Neisseria gonorrhoeae, gonor-
rhoea is transmitted by direct contact of
mucosal surfaces, and so proctitis is com-
monest in men or women participating in
receptive anal intercourse, although in
women it can occur due to transmucosal
spread of infected genital fluid. Symptoms
of proctitis are non-discriminatory includ-
ing lower abdominal pain, diarrhoea,
rectal bleeding and tenesmus; however, it
may be associated with an anorectal puru-
lent discharge. Diagnostic suspicion
should be raised in the presence of ureth-
ral discharge and/or pharyngeal
infection.2
Anogenital samples should be sent for
immediate Gram stain, in which the pres-
ence of Gram-negative diplococci are sug-
gestive of a diagnosis with a sensitivity of
90–95%2 (although the specificity of this
test may be lower than 60%).3 Nucleic
acid amplification tests (NAAT, eg, PCR),
although not yet licensed for this anatom-
ical site2 are more sensitive than culture
and based on available evidence should
be used for diagnosis. In addition, ano-
genital and pharyngeal swabs in the
appropriate transport medium (as advised
by the local microbiologist) should also
be sent for culture in order to determine
antibiotic sensitivities. A high proportion
of patients with confirmed gonococcal
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infection will also have chlamydia, and so involvement
of genitourinary medicine (GUM) specialists and
testing for co-infection must be undertaken in con-
firmed cases.
Treatment of rectal gonorrhoea without available
antibiotic sensitivities should be with ceftriaxone
500 mg intramuscularly once, alongside azithromycin
1 g orally once.2 Gonorrhoea is becoming increasingly
resistant to cefalosporins and so repeat testing is advis-
able following treatment to ensure eradication and to
prevent further resistance development. Azithromycin
co-treatment with ceftriaxone may improve eradica-
tion of gonorrhoea and aims to slow the development
of further cephalosporin resistance.
LYMPHOGRANULOMAVENEREUM
There are several serovars of Chlamydia trachomatis.
Serovars D–K may lead to superficial rectal mucosal
infection (see below); however, serovars L1, L2 and
L3 may lead to deeper invasive infection that can
affect submucosal tissue and lymphatics, thereby
allowing spread to lymph nodes. These invasive sero-
vars are responsible for lymphogranuloma venereum
(LGV), also known as lymphogranuloma inguinale,
lymphopatia venereum and Durand–Nicolas–Favre’s
disease.4 Previously uncommon in western popula-
tions, there have been several outbreaks of this condi-
tion in Europe and North America within the past
decade. Although LGV affects men and women, the
majority of cases occurs in men who have sex with
men (MSM). The commonest presentation of the con-
dition is proctitis, usually within several weeks of
sexual contact, with symptoms including proctalgia,
rectal bleeding and mucopurulent anal discharge.
Endoscopic features may mimic IBD proctitis with the
additional finding of purulent exudate. Advanced
infection may lead to perianal abscess, fistula forma-
tion and anorectal stricturing. LGV may also exhibit
extra-intestinal manifestations including reactive arth-
ritis and hepatitis.
Discriminating factors from IBD include urethral or
vaginal mucopurulent discharge, and painful inguinal
and femoral lymphadenopathy may be present that
can progress to abscess formation. Low-grade pyrexia
and rigors may also be discriminating signs.
GUM or infectious disease specialists should be con-
sulted in suspected or confirmed cases of LGV. A diag-
nosis requires mucosal sampling using anogenital
swabs and the detection of L1, L2 or L3 biovar C
trachomatis by NAAT and genotyping. Testing for
other STIs including HIV (which is particularly asso-
ciated with LGV), hepatitis B and C, syphilis and gon-
orrhoea should also be undertaken in confirmed
cases. Current European guidance on the management
of LGV recommends doxycyline 100 mg twice a day
for 21 days first line, or erythromycin 500 mg four
times a day for 21 days.4 Symptoms should abate
within 7–14 days. Patients should be advised to
abstain from sexual contact until completion of
therapy, and sexual partners within the preceding
3 months should be notified and screened for infec-
tion. A test of cure should be performed at least
4 weeks following completion of therapy.
CHLAMYDIA
Caused by C trachomatis serovars D–K, transmission
of chlamydia is similar to that of N gonorrhoeae.
Routine screening using NAAT in GUM clinics detects
rectal chlamydia in approximately 10% of MSM and
5% of women. Over 50% of chlamydial infection in
MSM is rectal without urethral infection.
Approximately 70% of rectal chlamydial infections
are asymptomatic; however, mild symptoms of diar-
rhoea and anal discharge may occur. Occasionally
these symptoms can be as severe as LGV or gonor-
rhoea. Microscopy of anal discharge may show the
presence of neutrophils but unlike gonorrhoea, chla-
mydia cannot be diagnosed by immediate Gram stain.
Endoscopy may show a ‘cobblestone’ appearance due
to the infiltration of underlying lymphoid follicles.
Although not licensed for extragenital sites, NAAT has
been shown to be sensitive and specific and should be
requested to diagnose rectal chlamydial infection.
Aptima combo 2 (Hologic Gen-Probe) is a transcription-
mediated assay that has the advantage of detecting both
N gonorrhoeae and C trachomatis. When requesting
NAAT for C trachomatis in the presence of proctitis,
genotyping for LGV should be requested as this is not
usually carried out on routine specimens.
Rectal chlamydia is best treated with doxycycline
100 mg twice a day for 1 week. (In cases of proctitis
in which LGV is a possibility a 3-week course of
doxycycline can be started pending the test results.
If LGV is excluded, the treatment can be stopped after
1 week.) An alternative is azithromycin 1 g as a single
dose but up to 20% treatment failure has been
observed and therefore a test of cure with repeat
NAATafter 6 weeks is recommended.
HERPES SIMPLEX VIRUS
Caused by either herpes simplex virus (HSV) type 1
or type 2, primary herpes simplex infection may be
asymptomatic, but 40% of men and 70% of women
will develop systemic features that include malaise,
headaches and muscle pains. HSV ascends peripheral
sensory nerves then lies dormant in sensory or auto-
nomic ganglia where it can later reactivate. Recurrent
Box 1 Gastroenterology curriculum 2010
Competency 2.c. Intestinal disorders: Inflammatory and infective conditions
▸ Recognises the range of important inflammatory conditions of the intestine
other than inflammatory bowel disease
▸ Knows the range of potential aetiologies including infection
▸ Knows the means of investigation of infectious diseases
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HSV occurs in approximately 60% of those infected
with type 1 HSV and 90% in type 2 HSV. Proctitis is
usually associated with anal intercourse and diagnostic
suspicion should be raised in the presence of perianal
vesicles or painful oral/anogenital ulceration.
PCR on rectal biopsy, or exudate from a lesion is
the current ideal diagnostic modality for rectal HSV.3
Recommended treatment for acute infection is 5 days
of either aciclovir 200 mg five times a day, aciclovir
400 mg three times a day, valaciclovir 500 mg twice a
day, or famciclovir 125 mg twice a day.5 For recurrent
HSV, aciclovir may be given four times a day for up to
1 year; however, only 20% of patients will see a sub-
sequent reduction in disease recurrence.
It should be appreciated that anogenital ulcers asso-
ciated with both HSV and syphilis lead to a 1.5 to
sevenfold increase in HIV transmission due to the
associated mucosal barrier breach, and so HIV testing
should be undertaken.
SYPHILIS
Caused by the spirochete Treponema pallidum, the
incidence of syphilis both in men and women has
steadily risen in recent years, especially so in MSM.6
Primary syphilis presents within 3 months of exposure
(on average within 2–3 weeks), with a painless solitary
ulcer (chancre, see figure 1) and regional lymphaden-
opathy that may affect the genitalia, mouth or rectum.
Figure 1 Solitary syphilitic chancre affecting (a) male and (b) female external genitalia. A chancre is the archetypal feature of
primary syphilis. These ulcers are classically anogenital, solitary, indurated and painless; however, in atypical cases they may be
multiple and painful, and can occur at extra-anogenital sites.
TRAINING MATTERS
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These ulcers are typically indurated with a clean base
and discharge serous fluid. If unidentified, primary
disease can progress to secondary syphilis typically in
6–12 weeks (but up to 2 years) later, in which bacter-
aemia leads to multisystem disease that may include
peripheral neuropathy, maculopapular rash (typically
palmoplantar, see figure 2), hepatitis, glomeruloneph-
ritis, meningitis or anterior uveitis. Secondary syphilis
can also manifest with oral ulceration (typically with a
snail tract distribution), proctitis and condylomata
lata, which are wart-like papules commonly perianal
or genital in anatomical origin. Covered in a greyish
exudate, condylomata lata are highly infectious.
Tertiary syphilis, which may occur several years fol-
lowing primary or secondary disease, can have major
neurological or cardiovascular sequelae. These include
dementia, paresis, seizures, aortitis or aneurysms.
Tertiary syphilis may also feature gumma, which are
granulomatous nodules or ulcers of the gastrointes-
tinal tract or buttocks.
Early infection up to 2 years after acquisition without
any manifestations of primary or secondary stages is
described as early latent syphilis. Primary, secondary and
early latent stages of syphilis are infectious, whereas the
later stages of tertiary syphilis are largely non-infectious.
Emphasis should therefore be placed on diagnosing and
treating primary, secondary and early latent syphilis
promptly so as to avoid later complications.
A diagnosis of syphilis can be made by dark ground
microscopy or PCR of ulcer exudate, condylomata
Figure 2 Palmoplantar rash in secondary syphilis. The skin eruption associated with secondary syphilis characteristically has a
palmoplantar distribution, is pink or dark red and not pruritic.
TRAINING MATTERS
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lata exudate or rectal biopsies. It may be 12 weeks
from infection until antibodies become detectable
within serum, and so a repeat blood sample 3 months
following last sexual risk may be required. When a
diagnosis is suspected or confirmed, GUM or infec-
tious disease specialists should be consulted. Contact
tracing and screening is necessary, as between 40–60%
of contactable sexual partners may be infected.6
First-line treatment of primary and secondary syphilis
is ideally with intramuscular benzyl benzathine penicillin
2.4 million units once. This form of penicillin is slowly
hydrolysed to benzylpenicillin giving sustained release,
and is advantageous as it ensures bioavailability and can
be supervised. Alternatively, intramuscular procaine
penicillin 600 000 units a day for 10–14 days can be
given. Second-line therapy is with doxycycline 100 mg
twice a day for 14 days. For tertiary syphilis prolonged
courses of the above therapies may be required.
OTHER SEXUALLY TRANSMITTED PATHOGENS
THAT MAY CAUSE PROCTITIS
Giardia lamblia (giardiasis) and Entamoeba histolytica
(amoebiasis) may also be inoculated by sexual
contact.3 7 Spread by the faecal oral route, sexual
transmission is most commonly seen in MSM.
Giardiasis
In giardiasis, protozoa adhere and replicate on the brush
border of the duodenum and jejunum, feeding on the
mucous secretions of the intestine. In some cases procti-
tis is evident. Classically patients will experience
foul-smelling steatorrhoea around 2–3 weeks following
infection. Diagnosis is by direct microscopy of faeces
that may reveal trophozoites (the motile active feeding
stage of the protozoan life cycle) in liquid faeces.
Oocysts may be seen in either liquid or solid faeces;
however, they may be excreted in a cyclical manner, and
so repeated stool tests or in some cases duodenal biopsy
or aspirate may be required to confirm the diagnosis.
Faecal antigen detection kits may also aid diagnosis.
Treatment of giardiasis is with metronidazole 400 mg
three times a day for 5 days.
Amoebiasis
Diarrhoea caused by amoebiasis ensues 2–4 weeks
following the ingestion of cysts, when trophozoites
breach the mucosa causing an inflammatory infiltrate
and subsequent proctocolitis. Diarrhoea, which can be
bloody, may persist for several weeks. Diagnosis of
E histolytica trophozoites or cysts is usually possible on
microscopic examination of stool specimens. Treatment
is with metronidazole 800 mg three times a day or tin-
dazole 2 g once a day for 5–8 days, coupled with diloxa-
nide furoate 500 mg three times a day for 10 days to
optimise eradication. Stool samples should be analysed
at monthly intervals for 3 months following therapy as a
test of cure, and further treatment should be provided if
persistent amoebiasis is identified.
IMPORTANT NON-INFECTIOUS DIFFERENTIAL
DIAGNOSES OF STI-INDUCED PROCTITIS
While certain genital, oral or systemic features may
suggest an STI cause of proctitis, it is important to be
aware that there are other less commonly encountered
non-infectious causes of proctitis that may display
similar characteristics. These include Behçet’s syn-
drome and solitary rectal ulcer syndrome (SRUS).
Behçet’s syndrome
Classically presenting with orogenital ulceration due
to an underlying vasculitis, Behçet’s syndrome can
also affect any part of the gastrointestinal tract.8 It
may present with perianal ulceration, fistulation, seg-
mental colitis and abdominal pain. Extra-intestinal
manifestations including arthritis, anterior uveitis
and erythema nodosum may lead to a misdiagnosis of
Crohn’s disease. This is further compounded by the
possibility of granulomata being found on biopsy. The
prevalence of Behçets syndrome is greatest in the
middle east, far east and the Mediterranean basin and
is highest in Turkey at 8–42 per 1000 people. Within
Behçet’s populations the prevalence of gastrointestinal
involvement varies, being highest at approximately
30% in Japan. Thrombophlebitis of the legs is fre-
quently observed and may be a subtle differentiating
feature between IBD and Behçet’s syndrome.
Endoscopically ulcers may appear well demarcated
and ‘punched out’, sometimes without surrounding
colitis. Histological examination of intestinal biopsies
may reveal a lymphocytic infiltration, classically with
vasculitis of small vessels; however, histology may be
indistinguishable from IBD. A diagnosis of Behçet’s
syndrome is consequently made clinically and is
dependent on the presence of recurrent oral ulcer-
ation plus two of recurrent genital ulceration, eye
lesions (uveitis or retinal vasculitis), skin lesions
(erythema nodosum, pseudofolliculitis, papulopustular
lesions, or acneform nodules in post-adolescent
patients), or a positive pathergy test at 24–48 h
(a sterile skin prick test that may lead to pustule or
nodule formation; however, this test is often nega-
tive).9 Treatment options for intestinal manifestations
of Behçet’s syndrome include 5-aminosalicylic acid,
sulfasalazine, or azathioprine. Corticosteroids may be
beneficial in some patients.
Solitary rectal ulcer syndrome
Commonly, SRUS presents with rectal bleeding, the
passage of mucous and regularly a sensation of incom-
plete evacuation.10 The condition is often associated
with rectal prolapse. Despite nomenclature, SRUS
may present with erythema of the rectal mucosa,
polypoid inflammation or multiple rather than single
ulcers. Consequently, a misdiagnosis of IBD or malig-
nancy may be made. Biopsy is therefore essential to
exclude rectal adenocarcinoma, and histological fea-
tures of thickened mucosa and smooth muscle
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extension from the muscularis into the lamina propria
are characteristic of SRUS. In comparison to IBD, an
inflammatory infiltrate is not a prominent finding on
histology. Diagnosis is often possible on the basis of
history and endoscopic examination; however, defe-
cating proctography and ultrasonography can be
useful aids to diagnosis. Common findings on defecat-
ing proctography include internal or external rectal
prolapse, often with incomplete rectal evacuation.
Endoanal ultrasound classically reveals a thickened
internal anal sphincter, and may show contraction or
failure of relaxation of the puborectalis muscle on
straining. Treatment options have variable results and
must be considered on an individual basis. These
include biofeedback therapy to modify defecation
behaviour, and surgical intervention including abdom-
inal rectopexy.
FURTHER CONSIDERATIONS WHEN MANAGING
PROCTITIS CAUSED BY A SEXUALLY
TRANSMITTED PATHOGEN
Patients diagnosed in the gastroenterology clinic with
an STI should be seen by an expert in sexual heath
and associated infections, when clear information
regarding their diagnosis should be provided to
patients and their sexual contacts. Partner notification
and screening should be undertaken (partners in pre-
ceding 3 months for primary syphilis, chlamydia,
LGV, or rectal gonorrhoea, and 2 years for secondary
or latent syphilis), and this may help to identify sexual
networks with a high risk of future transmission.
Empirical treatment for partners may be recom-
mended until negative results of investigations are
available. With respect to HSV, patients should be
given advice on transmission risks and sharing infor-
mation with partners. Co-infection with other sexu-
ally transmitted pathogens is common and so full
sexual health screening including HIV, hepatitis B and
C is advisable.
CONCLUSION
When evaluating a patient with either new-onset
disease, proctitis that has not responded to standard
treatments for Crohn’s disease or ulcerative colitis, or
in the presence of atypical clinical or laboratory fea-
tures, there are several differential diagnoses outlined
by this paper that must be considered. Box 2 describes
common or key discriminating features of these condi-
tions with respect to Crohn’s disease and ulcerative
colitis. Box 3 outlines risk factors for STIs that should
be considered by clinicians, and box 4 advises on
taking a sexual history in the gastroenterology clinic.
Sexual health experts should be consulted in cases of
confirmed or suspected STI, when further screening
for co-infection including HIV, hepatitis B and C
should then be undertaken, along with tests of cure
and partner identification as appropriate.
BEST OF FIVE QUESTIONS
Question 1
A 23-year-old man presented with an 8-week history
of bloody diarrhoea, severe anorectal pain and low-
grade pyrexia. On further questioning he also com-
plained of malaise, myalgia and arthralgia. He admit-
ted to unprotected receptive anal sexual intercourse
with two male partners in the preceding 6 months.
Perianal and rectal examination revealed two fluctu-
ant, tender areas of induration adjacent to the anal
verge suggestive of abscesses. An urgent flexible sig-
moidoscopy revealed inflamed, friable rectal mucosa
Box 2 Common or key discriminating features from
Crohn's disease or ulcerative colitis
Gonorrhoea
▸ Purulent urethral discharge
▸ Pharyngeal infection
▸ Gram-negative diploccoci on Gram stain of anogenital swabs
▸ Chlamydia co-infection common
Lymphogranuloma venereum
▸ Mucopurulent anal, urethral or vaginal discharge
▸ Painful inguinal or femoral lymphadenopathy possibly with associated
abscess formation
▸ Low-grade fever and pyrexia
▸ C trachomatis biovar L1, L2 or L3 identification on nucleic acid amplification
test and genotyping
Chlamydia
▸ Proctitis symptoms usually mild (often asymptomatic)
▸ Neutrophils may be seen on microscopy of anal discharge
▸ Gonorrhoea co-infection common
Herpes simplex virus
▸ Malaise, headaches and myalgia
▸ Perianal vesicles or ulcers
▸ Painful genital ulceration
▸ HSV type 1 or 2 identification on PCR
▸ Syphilis
▸ Painless rectal or orogenital chancre (primary disease)
▸ Snail tract oral ulceration
▸ Condylomata lata
▸ Associated neurological, cognitive and vascular co-morbidities (secondary
and tertiary disease)
▸ Gastrointestinal or glutaeal gummatous ulceration or nodules
Behçet's syndrome
▸ Punched-out oral ulceration
▸ Proctocolonic ulcers may not have surrounding proctocolitis.
▸ Lower limb thrombophlebitis
▸ Genital ulceration
▸ Eye and skin lesions common
▸ Positive pathergy test
Solitary rectal ulcer syndrome
▸ Rectal prolapse
▸ Smooth muscle extension from muscularis into lamina propria and relative
absence of inflammatory infiltrate on histology
Box 3 Risk factors associated with sexually trans-
mitted infections11
▸ Younger age (less than 25 years at highest risk)
▸ People from or who have visited countries with higher rates of STI
▸ Men who have sex with men
▸ Frequent partner change or multiple concurrent partners
▸ Early onset sexual activity
▸ Previous STI or previous contact with STI
▸ Alcohol or substance misuse
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with several large ulcers and spontaneous bleeding.
Rectal swabs sent for NAAT and genotyping revealed
the presence of C trachomatis genotype L1.
Which of the following is the most appropriate
treatment regimen:
A—Doxycycline 100 mg twice a day for 7 days
B—Erythromycin 250 mg four times a day for 21 days
C—Olfloxacin 400 mg a day for 7 days
D—Erythromycin 500 mg twice a day for 7 days
E—Doxycycline 100 mg twice a day for 21 days
Question 2
A 32-year-old man presents with a 6-week history of
diarrhoea, anorectal pain and maculopapular rash affect-
ing the trunk, hands and feet. Two years previously he
had been investigated for possible Crohn’s disease after
presenting with several perianal and anal verge ulcers.
These had resolved spontaneously and no formal diag-
nosis had been made. On further questioning he admit-
ted to a 4-week history of perianal swelling and several
oral ulcers with a snail track distribution on inspection.
Perianal inspection is demonstrated in figure 3.
What is the most likely causative organism:
A—HSV
B—T pallidum
C—N gonorrhoea
D—C trachomatis
E—Human papilloma virus
Question 3
A 40-year-old male patient of Turkish origin presented
to ophthalmology as an emergency with acute painless
reduced visual acuity in both eyes. Further questioning
revealed a several year history of intermittent diar-
rhoea, recurrent oral and penile ulceration, with oro-
genital scarring evident on examination. He also
complained of painful red nodules on the extensor
aspects of both forearms. One year previously he had
been diagnosed with anterior uveitis requiring pro-
longed steroid use. Slit lamp retinal examination
revealed multiple intraretinal haemorrhages, soft exu-
dates and macular oedema in both eyes.
What is the most likely diagnosis:
A—Crohn’s disease
B—Sarcoidosis
C—Behçet’s syndrome
D—Tuberculosis
E—Multiple sclerosis
Box 4 Components of and tips for taking a sexual
history in the gastrointestinal clinic12
Components
▸ Symptoms: Duration, association with genital or bladder symptoms, presence
and colour of discharge
▸ Partners: Last sexual intercourse, partner gender, establish number of part-
ners within preceding 3–6 months, partner symptoms, type of sexual inter-
course (oral, vaginal or anal)
▸ Contraception: Specifically the use of condoms
▸ History of STI: Previous diagnoses and treatment of STI or partner diagnoses/
treatment
▸ Foreign travel: Travel to areas of high incidence
▸ Social history: Including alcohol and drug misuse
▸ For women: Last menstrual period
Tips
▸ Speaking to the patient alone may allow them to speak more openly about
their symptoms and allow you to ask more detailed questions, as can utilis-
ing a sexual history proforma, used in many GUM clinics
▸ Seek permission and explain why you are asking personal questions
▸ Only ask what you need to know, avoid needlessly intrusive questions
Figure 3 Perianal inspection (question 2).
TRAINING MATTERS
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Question 4
A 32-year-old woman presented to the endoscopy
department for flexible sigmoidoscopy with a
1-month history of diarrhoea and abdominal pain.
Two months previously she had been treated in
primary care for chlamydia infection following a posi-
tive urine NAAT. Symptoms of dysuria and urethral
discharge had continued despite 7 days doxycycline
100 mg twice a day. Endoscopy revealed mildly ery-
thematous mucosa and loss of normal vascular pattern
in the rectum associated with a purulent discharge.
Anal and urethral swabs were obtained and the result-
ant Gram stain is shown in figure 4.
What is the most likely causative organism:
A—C trachomatis
B—HSV
C—Human papilloma virus
D—T pallidum
E—N gonorrhoea
ANSWERS
Answer 1: E
The symptoms described and positive testing for C
trachomatis serovar L1 are diagnostic of LGV. While a
7-day course of doxycycline 100 mg twice a day,
olfloxacin 400 mg a day or erythromycin 500 mg
twice a day would be appropriate to treat uncompli-
cated serovar D–K C trachomatis, LGV caused by
invasive serovar L1, 2, or 3 requires 21 days of
therapy, and while erythromycin would be appropri-
ate, a higher dose of 500 mg four times a day would
be required. The correct answer is therefore doxycy-
line 100 mg twice a day for 21 days.
Answer 2: B
The depicted flat-topped, papillomatous perianal
lesions are typical of condylomata lata, a feature of sec-
ondary syphilis caused by T pallidum. The described
oral ulceration and macular rash with a palmoplantar
distribution are also typical of secondary syphilis. The
previous perianal ulcers are likely to have represented
multiple primary syphilitic chancres, as although these
are classically singular, multiple lesions may be seen.
Answer 3: C
The ocular findings are consistent with retinal vascu-
litis that can be confirmed by fluorescein angiography.
The painful nodules on his forearms are suggestive of
erythema nodosum, and these diagnoses associated
with previous anterior uveitis, recurrent orogenital
ulceration and gastrointestinal symptoms are consist-
ent with Behçet’s syndrome. The highest prevalence
of Behçet’s syndrome is in Turkey. Tuberculosis, sar-
coidosis and Crohn’s disease are among the differen-
tial diagnoses; however, recurrent genital ulceration
would be uncommon and is more typically a finding
of Behçet’s syndrome. Orogenital ulceration is not a
feature of multiple sclerosis.
Figure 5 Gram stain of swab exudate (answer 4). Arrows
point towards neutrophils containing intracellular Gram-negative
diplococci.
Figure 4 Gram stain of swab exudate (question 4).
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Answer 4: E
The Gram stain reveals numerous neutrophils, many
with intracellular Gram-negative diplococci (arrows in
figure 5) consistent with N gonorrhoea infection.
Co-infection with gonorrhoea is commonly associated
with chlamydia, and gonorrhoea would not have
responded to the previous course of doxycycline,
hence the patient’s ongoing symptoms. Rectal infec-
tion with gonorrhoea can occur due to the transmuco-
sal spread of infected urethral discharge. Appropriate
therapy for gonorrhoea proctitis includes ceftriaxone
500 mg intramuscularly once, plus oral azithromycin
1 g once.
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